NASDAQ · LEGN
Legend Biotech Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for LEGN: Nov 10, 2026
Legend Biotech Corporation American Depositary Shares is expected to report earnings on 11/10/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $0.01. The reported EPS for the same quarter last year was $-0.11.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.01 | $0.08 | $-0.07 | 6 |
| Dec 2026 | $0.05 | $0.10 | $-0.02 | 6 |
| Mar 2027 | $0.23 | $0.28 | $0.13 | 4 |
| Jun 2027 | $0.30 | $0.36 | $0.21 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · NASDAQ.com · The Motley Fool- Zacks · Oct 27, 8:30 AM EDTLegend Biotech Corporation Sponsored ADR (LEGN) Crossed Above the 50-Day Moving Average: What That Means for InvestorsIs it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
- RTTNews · Oct 15, 10:16 AM EDTLegend Biotech Wins FDA Clearance For In Vivo CAR-T Therapy LB2501; Stock Up(RTTNews) – Legend Biotech Corporation (LEGN) announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for LB2501, an investigational in vivo CAR-T therapy for relapsed or refractory B-cell malignancies, including B-cel
- RTTNews · Sep 15, 8:38 AM EDTLegend Biotech Appoints Ingrid Zhang As CEO(RTTNews) – Legend Biotech Corp. (LEGN), a cell therapy company, on Tuesday appointed Ingrid Zhang as Chief Executive Officer, effective September 15.
- NASDAQ.com · Sep 11, 4:24 PM EDTAfter Hours Most Active for Sep 11, 2026 : KHC, ACWX, PATH, TSLL, GRAB, F, LEGN, AAPL, XPEV, KVUE, T, BMNRThe NASDAQ 100 After Hours Indicator is down -2.61 to 29,365.83. The total After hours volume is currently 158,788,347 shares traded.The following are the most active stocks for the after hours session: The Kraft Heinz Company (KHC) is +0.1383 at $24.74, with 40,545,978 shares t
- The Motley Fool · Aug 31, 5:04 AM EDTJohnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.J&J's portfolio primarily includes small biotech and medtech companies.
- RTTNews · Aug 12, 3:37 AM EDTLegend Turns Profitable In Q2 As CARVYKTI Sales Jump By 50%(RTTNews) – Legend Biotech Corporation (LEGN) released financial results for the second quarter ended June 30, 2026. The commercial-stage company turned profitable in the second quarter, compared with a loss in the prior-year quarter, driven by higher collaboration revenue and im
- The Motley Fool · Aug 11, 8:58 PM EDTLegend Biotech (LEGN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 11, 9:04 AM EDTLegend Biotech Q2 Earnings Call HighlightsCPI Data Sparks Rally in Biotech StocksLegend Biotech (NASDAQ:LEGN) reported second-quarter 2026 results marked by continued global growth for CARVYKTI and the company’s first quarter of company-wide profitability on both an IFRS and adjusted basis, management said during its ear
- NASDAQ.com · Aug 10, 4:00 PM EDTPre-Market Earnings Report for August 11, 2026 : CAH, SE, ESLT, ARMK, ONON, SFD, VG, MIDD, AMTM, TME, LEGN, ETORThe following companies are expected to report earnings prior to market open on 08/11/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Cardinal Health, Inc. (CAH)is reporting for the quarter ending June 30, 2026. The medical/dental supplies company
- RTTNews · Jul 27, 8:31 AM EDTLegend Biotech Appoints Bash As Interim CEO Following Ying Huang's Departure; Stock Down(RTTNews) – Legend Biotech Corporation (LEGN), a clinical-stage biopharmaceutical company, announced Monday that its Board of Directors had appointed Alan Bash as the interim Chief Executive Officer (CEO) after Ying Huang stepped down from the role on July 24, 2026.
- The Motley Fool · Jun 27, 2:05 PM EDT2 Biotech Stocks Worth Buying Before Their Potential BuyoutsLegend and BioNTech are commercial-stage biotechs.
- RTTNews · Jun 24, 6:41 AM EDTCalidi Biotherapeutics Appoints Former Celgene Executive Corsee Sander To Board Of Directors(RTTNews) – Calidi Biotherapeutics, Inc. (CLDI) announced the appointment of Corsee Sanders as an independent director on the company's Board of Directors, effective from June 17, 2026.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Legend Biotech Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.